October 17, 2019
A Step Toward Bioengineered Transplantable Livers
More than four million American suffer from chronic end stage liver disease, according to the Centers for Disease Control and Prevention, and a liver transplant can mean the difference between life and death for some patients. However, livers are in short supply, and the number of people awaiting new livers far exceeds the number of […]
Tags: bioengineered organs, liver transplant, regenerative medicine, scott nyberg, transplant
October 10, 2019
Regenerative Strategies for Osteoarthritis: Jonathan Finnoff, D.O.
Osteoarthritis is the most common form of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of your bones wears down over time. While the significant pain, limited activity, and decreased quality of life that affect patients with osteoarthritis can usually be managed, the damage to joints can’t […]
Tags: Dr. Jonathan Finnoff, osteoarthritis, PRP, regenerative medicine, stem cells
September 20, 2019
Biomanufacturing in Discovery Square Building will Bring New Options to Patients
The grand opening of One Discovery Square opens a new chapter in biomanufacturing focused on connecting patients with complex medical conditions with novel biotherapeutic solutions. The Mayo Clinic Center for Regenerative Medicine Advanced Biomanufacturing facility is one of the Mayo tenants in the building focused on the acceleration of new health care products to market […]
Tags: Advanced Biomanufacturing Facility, Discovery Square, DMC, Dr. Andre Terzic, Dr. Atta Behfar, Mayo Clinic Center for Regenerative Medicine, regenerative medicine
September 12, 2019
Researching Stem Cells for Kidney Disease: LaTonya Hickson, M.D.
Diabetic kidney disease (DKD) is a serious complication of diabetes. Up to 40 percent of people with diabetes eventually develop kidney disease. With no long-term treatment available, many patients will progress to end stage kidney disease requiring either dialysis or a kidney transplant. Research is underway to keep people from progressing to kidney failure, and […]
Tags: diabetes, diabetic kidney disease, Dr. LaTonya Hickson, kidney failure, Mayo Clinic Center for Regenerative Medicine, regenerative medicine, stem cells
August 29, 2019
Gerstner Regenerative Medicine Initiative: Tracking Outcomes and Supporting Clinical Trials
One of the challenges of integrating regenerative medicine into daily patient care is that it is so new, there is not a lot of available data to consider when determining best practices. A recent grant will help track information on how patient do after clinical trials. The Gerstner Regenerative Medicine Initiative, funded through a grant […]
Tags: Dr. Shane Shapiro, Gerstner Regenerative Medicine Initiative, osteoarthritis, Regenerative Evidence-Based Outcome Registry, regenerative medicine, stem cells
August 22, 2019
New Florida Building Dedicated to Medical Discovery and Innovation
The grand opening of the new Discovery and Innovation Building at Mayo Clinic’s Florida campus signals a new era of integrating regenerative medicine into daily practice. Regenerative medicine seeks to tap the body’s ability to replace, restore or regrow damaged or diseased cells, tissues and organs. A hub of research and technology, the new building […]
Tags: Dr. Abba Zubair, Dr. Atta Behfar, Innovation, lung transplantation, Mayo Clinic Discovery and Innovation Buildling, Mayo Clinic Life Science Incubator, regenerative medicine, stem cells
July 30, 2019
Bioartificial Liver: Bridge to Liver Regeneration
The liver has the greatest regenerative capacity of any organ in the body. However, when the liver is injured beyond its ability to regenerate itself, and a transplant is not readily available, there are few options for patients. Led by Scott Nyberg, M.D., Ph.D., researchers are refining their own version of a bioartificial liver, known […]
Tags: Bioartificial Liver, Center for Regenerative Medicine, Dr. Scott Nyberg, Liver Transplantation, regenerative medicine, stem cells, transplant
July 26, 2019
Research for Infants with HLHS Moves Forward
Hypoplastic left heart syndrome (HLHS) is a complex and rare heart defect present at birth in which the left side of a child’s heart is severely underdeveloped. At Mayo Clinic, physicians and researchers in the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome are looking for ways to delay or even prevent heart failure […]
Tags: clinical trial, Dr. Timothy Nelson, heart disease, HLHS, hypoplastic left heart syndrome, Medical Research, phase I trial, regenerative medicine, stem cells, Todd and Karen Wanek Family Program for HLHS
June 28, 2019
Researching Stem Cell Therapy for Hemorrhagic Stroke
Stroke is the leading cause of permanent disability in the U.S., striking nearly 800,000 people each year, according to the Centers for Disease Control and Prevention. In the last decade, there has been preclinical research that led to a small number of early phase clinical trials using mesenchymal stem cells (MSCs) as a possible treatment to reverse […]
Tags: mesenchymal stem cells, MSCs, regenerative medicine, stem cells, stroke, Toni Turnbull, William Freeman
June 24, 2019
HLHS Consortium Gives Hope to Babies with Rare Congenital Heart Defect
Hypoplastic Left Heart Syndrome (HLHS) is a rare disease that affects approximately 1 of every 4,300 babies every year. HLHS is a congenital heart defect in which the left side of the heart is underdeveloped. It occurs during fetal growth when the baby’s heart is developing. Without immediate intervention after birth, 95% of infants with […]
Tags: HLHS, HLHS consortium, hypoplastic left heart syndrome, Ochsner Hospital for Children, regenerative medicine, stem cells, Timothy Nelson